UCB - Annals of the Rheumatic Diseases Publishes Results from Two Bimekizumab Phase 3 Studies in Axial Spondyloarthritis (18.01.2023)

18 januari 2023

Ucb

Bijlagen

82ffbb0008ebf4e...